MicroRNA-296: A promising target in the pathogenesis of atherosclerosis?

36Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Atherosclerosis has been recognized as an inflammatory disease involving the vascular wall. MicroRNAs are a group of small noncoding RNAs to regulate gene expression at the transcriptional level through mRNA degradation or translation repression. Recent studies suggest that miR-296 may play crucial roles in the regulation of angiogenesis, inflammatory response, cholesterol metabolism, hypertension, cellular proliferation and apoptosis. In this review, we primarily discussed the molecular targets of miR-296 involved in the development of atherosclerosis, which may provide a basis for future investigation and a better understanding of the biological functions of miR-296 in atherosclerosis.

Cite

CITATION STYLE

APA

Li, H., Ouyang, X. P., Jiang, T., Zheng, X. L., He, P. P., & Zhao, G. J. (2018, March 26). MicroRNA-296: A promising target in the pathogenesis of atherosclerosis? Molecular Medicine. BioMed Central Ltd. https://doi.org/10.1186/s10020-018-0012-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free